Replies to post #264004 on Innovation Pharmaceuticals Inc (IPIX)

[MXAMDUD]

maybe all that is true. but PR's about traveling to trade conferences is a waste.

[To infinity and beyond!]

why talk efficacy when you can talk potential? Why bother?

just like those vey large markets for psoriasis for an oral formulation- if only P worked
just like those very large markets for mucositis for a preventive swish- if only BOM worked

Hang on till 2022 or thereabouts and we will find out about oral B
in the meantime we can have a lot of fun talking abut the very large oral IBD market...

Till then...it's back to B UP which had no control group- should we worry about that? Of course we should.